SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Oppenheimers upgrade to Outperform, citing rising contract values and early monetization of agentic-AI traffic, is driving attention to Fastly. Traders are cheering the rally and AI-growth thesis, while some dismiss the upgrade as hype and point to the stocks sharp swings.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscalers Investor Day is driving attention, with management reaffirming its fiscal-year outlook and highlighting an ambitious long-term ARR goal and an AI-security collaboration with IBM and Red Hat; analysts responded with multiple price-target increases. Bulls are encouraged by the strategy and momentum, while skeptics question whether the long-term growth ambitions justify the valuation.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironments fiscal Q1 results beat expectations and its funded backlog reached a record, prompting renewed optimism about drone and counter-drone demand. Traders are divided because management maintained its full-year outlook, leaving concerns about growth, profitability and converting orders into revenue alongside the bullish reaction to the backlog.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is drawing attention ahead of its third-quarter earnings report, with traders weighing its higher annual outlook, analyst estimate changes and growth prospects against recent share-price weakness. Views are mixed: some expect the rally to continue, while others point to a pullback and question the stocks performance.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Disruption and security risks around the Strait of Hormuz are the dominant focus, with traders linking constrained tanker traffic and elevated freight rates to BWETs exposure to tanker-freight futures. Bulls see the shipping squeeze as supportive, while bears warn that de-escalation could unwind rates quickly and point to the funds sharp, volatile run.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

Traders are using SQQQ to hedge or bet on a Nasdaq pullback, citing concerns about stretched tech and AI valuations, market breadth, and macro risks such as yields and geopolitical tensions. Others point to the Nasdaqs strength and warn that SQQQs leveraged, daily-reset structure can erode value, making it a risky longer-term hold.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms strong quarterly results and upbeat outlook, followed by a wave of analyst upgrades, are driving attention. Traders are split between buyers expecting the growth story to support a recovery and sellers pointing to the sharp post-earnings pullback, profit-taking, and interest-rate concerns.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

A Goldman Sachs upgrade to Buy is being cited alongside Palantirs breakout to fresh highs, with traders pointing to AI demand and strong momentum. Bulls are celebrating the move and discussing a possible short squeeze, while skeptics warn that the valuation is stretched and the rally could reverse.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is rebounding after a sharp selloff triggered by CEO CJ Desais abrupt departure for Meta; traders calling the drop an overreaction point to former CEO Dev Ittycherias return as interim chief and positive Investor Day commentary, including raised guidance and a larger buyback authorization. Others remain cautious about leadership succession and valuation.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINK is drawing attention amid a volatile rebound and renewed breakout attempts, with bullish traders citing Chainlinks institutional tokenization and interoperability use cases, including a reported Coinbase/Base integration. Skeptics see the moves as short-lived and question whether network adoption translates into value for the token, while others point to Bitcoins influence on LINKs price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why You Should Add LPCN Stock to Your Portfolio Now

Lipocine's Tlando royalties, Brlizio's phase III trial and broader pipeline offer multiple potential growth drivers and catalysts.

Nasdaq Falls Over 100 Points; US Crude Inventories Decline

U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciencesread more...

Oral Testosterone Capsule Wins Canadian Approval, Shares Up

Testosterone replacement therapy has largely relied on delivery methods that come with practical tradeoffs. Injections require needles and can cause injection-site reactions, while topical gels can be messy and carry a risk of transferring testosterone to others through skin contact. An oral treatment that does not require dose titration offers another approach in a Canadian market where more than 700,000 testosterone replacement therapy prescriptions are written annually.Shares of Lipocine Inc. (NASDAQ: LPCN) are moving higher Wednesday after the company announced that Health Canada has ...

Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement Therapy

Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement Therapy Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement TherapyPR NewswireSALT LAKE CITY, Oct. 7, 2026SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a...

Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?

Lipocine (LPCN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression

Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum DepressionPR NewswireSALT LAKE CITY, Sept. 14, 2026 Study informed by encouraging exploratory efficacy findings and a...

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire SALT LAKE CITY, Sept. 10, 2026 SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty...

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 PR Newswire SALT LAKE CITY, Aug. 4, 2026 SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty...

Lipocine Appoints Michael J. Grissinger to Board of Directors

Lipocine Appoints Michael J. Grissinger to Board of Directors Lipocine Appoints Michael J. Grissinger to Board of Directors PR Newswire SALT LAKE CITY, Aug. 3, 2026 SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary...

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 PR Newswire SALT LAKE CITY, June 4, 2026...

• Reported GAAP EPS of -$0.32 up 21.95% YoY
• Reported revenue of $0.19M down -69.48% YoY

Lipocine Inc. faces significant challenges including failure to meet the primary endpoint in a Phase 3 trial, data validity concerns at a clinical site, and a widening quarterly net loss.

Lipocine Inc. demonstrated potential efficacy for LPCN 1154 in post hoc analysis, initiated a new clinical trial, and achieved international regulatory approval for TLANDO in the United Arab Emirates.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

LPCN Stock Crashes 78%— Here’s Why 

Equity

Extremely Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.72
Prev Close	$1.93
Open	$1.89
Dividend Yield	0.00%
50-Day Moving Average	$2.15
Beta	0.75
Avg. Volume	33,440.80
PE Ratio	-0.92

52-Week High	$12.37
52-Week Low	$1.72
Market Capitalization	$15.91M
EPS (Annual)	-$1.77
Price to Book	0.65
Revenue Per Employee	$141,191.21

Feed

News

Sentiment

Earnings

Fundamentals

Info

LPCN Fundamentals